Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
Haematologica|August 6, 2013
Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomesSameer A Parikh, Kari G Rabe, Neil E Kay, et al.
Annals of Epidemiology|November 14, 2012
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of genderJennifer L Kelly, Zachary S Fredericksen, Mark Liebow, et al.
Blood|November 19, 2008
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcomeTait D Shanafelt, Neil E Kay, Greg Jenkins, et al.
Vaccine|January 19, 2021
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)Jennifer A Whitaker, Sameer A Parikh, Tait D Shanafelt, et al.
Cancer|August 8, 2013
Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL)Tait Shanafelt, Mark C Lanasa, Timothy G Call, et al.
Cancer|June 26, 2010
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemiaTait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Journal of Oncology Practice|March 26, 2015
Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levelsTait D Shanafelt, Bijan J Borah, Heidi D Finnes, et al.
Haematologica|June 20, 2015
Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experiencePaolo Strati, Samih H Nasr, Nelson Leung, et al.
Blood|March 16, 2013
Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)Tait D Shanafelt, Alan G Ramsay, Clive S Zent, et al.
Experimental Hematology|May 7, 2022
Serum B-Cell maturation antigen is an independent prognostic marker in previously untreated chronic lymphocytic leukemiaCamilia M Soof, Tanya M Spektor, Sameer A Parikh, et al.
Pageof 18